Evaluation of Systemic Microvascular Reactivity After Ingestion of an Energy Drink in Young Male Volunteers
NCT ID: NCT05575895
Last Updated: 2022-10-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
22 participants
OBSERVATIONAL
2020-01-10
2022-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Methods: Systemic MR was evaluated in the skin of the forearm using laser speckle contrast imaging with acetylcholine (ACh) iontophoresis before, 90 and 180 minutes after the consumption of one can of ED or the same volume of water (control), followed by postocclusive reactive hyperemia (PORH).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Energy Drinks and Vascular Function
NCT03324256
The Effect of Energy Drink Ingredients on Cardiovascular Function in Men and Women 18-39 Years Old
NCT04149717
Cardiovascular Effects of Energy Drinks in Healthy Adults
NCT01940822
Effects of Chronic Energy Drink Consumption on Cardiometabolic Endpoints
NCT03840863
Impact of Energy Drinks on Cardiovascular Endpoints
NCT01329679
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Energy Drink
Ingestion of 250 ml of the energy drink (Red Bull®)
\- Evaluation of systemic skin microvascular endothelial function Laser-based method for evaluating non-invasive, operator-independent systemic microvascular function that detects microvascular flow in the skin for the evaluation of systemic vascular endothelial function.
Ingestion of the energy drink (Red Bull®)
Ingestion of 250 ml of the energy drink (Red Bull®)
Control
Ingestion of 250 ml of mineral water (Minalba®)
\- Evaluation of systemic skin microvascular endothelial function Laser-based method for evaluating non-invasive, operator-independent systemic microvascular function that detects microvascular flow in the skin for the evaluation of systemic vascular endothelial function.
Ingestion of mineral water
Ingestion of 250 ml of mineral water (Minalba®)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ingestion of the energy drink (Red Bull®)
Ingestion of 250 ml of the energy drink (Red Bull®)
Ingestion of mineral water
Ingestion of 250 ml of mineral water (Minalba®)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* being on regular medication;
* using illicit drugs;
* being allergic to coffee, taurine or any of the components of the selected energy drink; - -
* having a body mass index ≥ 30 kg/m2.
18 Years
35 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Cardiology, Laranjeiras, Brazil
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eduardo Tibirica, MD, PhD
Senior researcher
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Institute of Cardiology, Ministry of Health, Brazil
Rio de Janeiro, , Brazil
Eduardo Tibiriçá
Rio de Janeiro, , Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CAAE 13135219.0.0000.5272
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.